Navigation Links
China Pharma Holdings, Inc. to Report Second Quarter 2011 Financial Results on August 11, 2011
Date:8/3/2011

HAIKOU, China, Aug. 3, 2011 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it plans to release its second quarter 2011 financial results before the market opens on Thursday, August 11, 2011.

The Company will hold a conference call at 8:30 am ET on August 11, 2011 to discuss second quarter 2011 results. Listeners may access the call by dialing 1-866-831-6272 or 1-617-213-8859 for international callers, access code: 72860215. A webcast will also be available through CPHI's website at http://www.chinapharmaholdings.com. A replay of the call will be accessible through August 18, 2011 by dialing 1-888-286-8010 or 1-617-801-6888 for international callers, access code: 99608603.

About China Pharma Holdings, Inc.China Pharma Holdings, Inc. is a specialty pharmaceutical company with rapidly growing profit that develops, manufactures, and markets treatments for a wide range of high incidence and high mortality conditions in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective, high margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding distribution network across 30 provinces, municipalities and autonomous regions. The Company is registered in Delaware, USA. Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson), located in Haikou City, Hainan Province, China, is a wholly owned subsidiary of China Pharma Holdings, Inc. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com.Contact:China Pharma Holdings, Inc.Phone: +86-898-6681-1730 (China)Email: hps@chinapharmaholdings.com
'/>"/>

SOURCE China Pharma Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
2. China Kanghui Holdings to Report Second Quarter 2011 Financial Results on August 16, 2011
3. China Nuvo Solar Target Acquisition SurgLine Announces Third-Party Distribution Agreement With OptiMedical, Corp.
4. Boston Scientific Announces Five-Year, $150 Million Investment in China to Accelerate Commercial Expansion
5. PolyGel Signs Long Term Exclusive Agreement With Chinas Largest Distributor of Healthcare Products
6. China Cardiac Catheters and Guidewires - Market Trends Till 2016
7. Aeras and China National Biotech Group Sign Memorandum of Understanding for TB Vaccine R&D Collaboration
8. Infusion Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
9. China Nuvo Solar Announces Definitive Agreement Signed to Acquire Medical Products company SurgLine, Inc.
10. China Sky One Medical Wins Bidding Process on Land Use Rights Covering Land at Song Bei District in Harbin
11. China Medical Technologies Announces the Filing of its Annual Report on Form 20-F for the Fiscal Year Ended March 31, 2011 with the SEC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... SAN DIEGO , March 29, 2017 /PRNewswire/ ... company focused on transforming spine surgery with minimally ... Drug Administration (FDA) 510(k) clearance of the CoRoent® ... at multiple contiguous levels in the cervical spine. ... cervical cage to be used at up to ...
(Date:3/29/2017)... , March 29, 2017 NetworkNewsWire ... ... the public safety in regulating marijuana, but economic arguments also ... creation, and reduced law enforcement costs. However, to legalize and ... provided by SinglePoint, Inc. (OTC: SING) ( SING Profile ), ...
(Date:3/29/2017)... /PRNewswire/ - Medicure Inc. ("Medicure") (TSXV:MPH, OTC:MCUJF), a specialty ... year ended December 31, 2016 after market close ... being released later than the previous fiscal year,s ... operations and balances of Apicore from the acquisition ... filing date meets TSX Venture Exchange listed company ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 29, 2017 , ... AngioGenesis Labs sold 300 bottles ... AngioGenesis Labs, makers of HeartBoost, BrainBest and BeautyBest, achieved these results while doing ... an over the counter heart healthy drink, can reduce Arterial Plaque, Lower Blood ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... growing as it continues developing an ANSI-approved, consensus-based American National Standard for ... plans to publish the first ANSI-approved GMP standard for dietary supplements this ...
(Date:3/29/2017)... ... March 29, 2017 , ... HealthCareMandA.com will host an ... 20, 2017, at 1:00 PM ET. A recording of the webinar will also be ... Series. , Home health and hospice companies are still popular targets for healthcare investors. ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... of Gastrointestinal Oncology™ (SOGO™), a specialized continuing medical education conference for clinicians who ... at Intercontinental Time Square, New York. , The program will be led ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Tuesday, March 28, ... American public to take the Diabetes Risk Test to find out if they are ... Angeles World Airports will light up the evening sky by programming the LAX pylons ...
Breaking Medicine News(10 mins):